Evaluation of functional and malignant adrenal incidentalomas

Archives of Internal Medicine

Volumn 170, Issue 22, 2010, Pages 2017-2020

  Ng, Vanessa W S ^a   Ma, Ronald C W ^a   So, Wing Yee ^a   Choi, Kai Chow ^b   Kong, Alice P S ^a   Cockram, Clive S ^a   Chow, Chun Chung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CATECHOLAMINE; HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADRENAL DISEASE; ADRENAL INCIDENTALOMA; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL EVALUATION; FEMALE; HONG KONG; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE; CATECHOLAMINES; CORTICOTROPIN-RELEASING HORMONE; EARLY DETECTION OF CANCER; FEMALE; HONG KONG; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78650087798     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.441     Document Type: Article

References (19)

1. Gross MD, Shapiro B. Clinical review 50: clinically silent adrenal masses. J Clin Endocrinol Metab. 1993;77(4):885-888. (Pubitemid 23301457)
2. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003;138(5):424-429. (Pubitemid 36262654)
3. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev. 1995;16(4):460-484.
4. Young WF Jr. Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol Metab Clin North Am. 2000;29(1):159-185.
5. Mantero F, Terzolo M, Arnaldi G, et al; Study Group on Adrenal Tumors of the Italian Society of Endocrinology. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab. 2000;85(2):637-644.
6. Terzolo M, Reimondo G, Bovio S, Angeli A. Subclinical Cushing's syndrome. Pituitary. 2004;7(4):217-223.
7. Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab. 2000;85(4):1440-1448. (Pubitemid 32289484)
8. Terzolo M, Pia A, Alì A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87(3):998-1003.
9. Torlontano M, Chiodini I, Pileri M, et al. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab. 1999;84(7):2381-2385.
10. Tauchmanovà L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab. 2002;87(11):4872-4878. (Pubitemid 35316318)
11. Fardella CE, Mosso L, Gómez-Sánchez C, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85(5):1863-1867. (Pubitemid 32269290)
12. Schwartz GL, Chapman AB, Boerwinkle E, Kisabeth RM, Turner ST. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clin Chem. 2002;48(11):1919-1923. (Pubitemid 35222749)
13. Rossi GP, Bernini G, Caliumi C, et al; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293-2300. (Pubitemid 44873058)
14. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol. 1993;20(5):296-298. (Pubitemid 23140199)
15. Kudva YC, Young WF Jr, Thompson GB, Grant CS, van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist. 1999;9(2):77-80. (Pubitemid 29165873)
16. Krane NK. Clinically unsuspected pheochromocytomas: experience at Henry Ford Hospital and a review of the literature. Arch Intern Med. 1986;146(1):54-57. (Pubitemid 16158627)
17. Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma: review of a 50-year autopsy series. Mayo Clin Proc. 1981;56(6):354-360.
18. Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab. 2006;91(6):2027-2037. (Pubitemid 43854976)
19. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis andmanagement. Endocr Rev. 2004;25(2):309-340. (Pubitemid 38528713)